Ibrutinib for Patients with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma: A Meta-Analysis of Randomized Controlled Trials

被引：0
|
作者：
Zhang, Shijia [1 ]
Sanchez, Larysa [1 ]
Liu, Jieqi [1 ]
Chang, Victor [2 ]
Goldberg, Stuart L. [3 ]
机构：
[1] Rutgers New Jersey Med Sch, Dept Med, Newark, NJ USA
[2] Hematol Oncol Sect, VA New Jersey Hlth Care Syst, East Orange, NJ USA
[3] Hackensack Univ Med Ctr, John Theurer Canc Ctr, Hackensack, NJ USA
来源：
BLOOD | 2016年 / 128卷 / 22期
关键词：
D O I：
10.1182/blood.V128.22.5596.5596
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5596
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Safety Analysis of Four Randomized Controlled Studies of Ibrutinib in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Mantle Cell Lymphoma
    O'Brien, Susan
    Hillmen, Peter
    Coutre, Steven
    Barr, Paul M.
    Fraser, Graeme
    Tedeschi, Alessandra
    Burger, Jan A.
    Dilhuydy, Marie-Sarah
    Hess, Georg
    Moreno, Carol
    Cramer, Paula
    Liu, Emily
    Chang, Stephen
    Vermeulen, Jessica
    Styles, Lori
    Howes, Angela
    James, Danelle F.
    Patel, Kalpesh
    Graef, Thorsten
    Valentino, Rudolph
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 (10): : 648 - +
  • [2] Efficacy of Ibrutinib in Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma: A Combined Analysis of Three Phase III Randomized Controlled Trials
    Swarup, Sriman
    Quick, Donald P.
    Sultan, Anita
    D'Cunha, Nicholas
    Htut, Thura Win
    Hlaing, Pwint Phyu
    Sharma, Upama
    Adhikari, Nimesh
    Aung, Ye
    Han, Myat Min
    Myat, Yin Mon
    Hardwicke, Fred
    Tijani, Lukman
    Thein, Kyaw Zin
    [J]. BLOOD, 2019, 134
  • [3] Efficacy of Ibrutinib in Newly Diagnosed Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma: A Combined Analysis of Four Phase III Randomized Controlled Trials
    Sultan, Anita
    Graf, Chandler
    Quick, Donald P.
    Swarup, Sriman
    Kopel, Jonathan
    Htut, Thura Win
    Adhikari, Nimesh
    Han, Myat Min
    Myat, Yin Mon
    Awasthi, Sanjay
    Tijani, Lukman
    D'Cunha, Nicholas
    Thein, Kyaw Zin
    [J]. BLOOD, 2019, 134
  • [4] Combined Ibrutinib and Venetoclax for Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
    Awan, Farrukh T.
    [J]. CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2020, 18 (01) : 13 - 14
  • [5] Risk of Infection with Ibrutinib in Patients with Chronic Lymphocytic Leukemia: A Systematic Review and Meta-analysis of Phase III Randomized Controlled Trials
    Ball, Somedeb
    Vutthikraivit, Wasawat
    Maiti, Abhishek
    Short, Nicholas J.
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 : S215 - S215
  • [6] Chemotherapeutic options in chronic lymphocytic leukemia: A meta-analysis of the randomized trials
    Geisler, C
    Hansen, MM
    Yeap, BY
    Wiernik, P
    Binet, JL
    Chastang, C
    Dighiero, G
    Travade, P
    Jaksic, B
    Brugiatelli, M
    Kimby, E
    Catovsky, D
    Hamblin, T
    Richards, S
    Bosch, F
    Fontanillas, M
    Montserrat, E
    Alison, R
    Clarke, M
    Duong, H
    Elphinstone, P
    Evans, V
    Godwin, J
    Gray, R
    Greaves, E
    Hicks, C
    James, S
    Mead, G
    Peto, R
    Richards, S
    Wheatley, K
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (10) : 861 - 868
  • [7] Evaluating CR as a surrogate endpoint for PFS in R/R chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL): A meta-analysis of randomized controlled trials (RCT)
    Wang, Lin
    Disher, Tim
    Liu, Fei Fei
    Kurt, Murat
    Perna, Serena K.
    Aronitz, Elise
    Eyre, Toby A.
    Davids, Matthew Steven
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [8] Randomized Controlled Trials in Relapsed/Refractory Chronic Lymphocytic Leukemia: A Systematic Review and Meta-Analysis
    Police, Rachel L.
    Trask, Peter C.
    Wang, Jianmin
    Olivares, Robert
    Khan, Shahnaz
    Abbe, Adeline
    Colosia, Ann
    Njue, Annete
    Sherri, Beth
    Ruiz-Soto, Rodrigo
    Kaye, James A.
    Hamadani, Mehdi
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2015, 15 (04): : 199 - 207
  • [9] Impact of Ibrutinib Dose Reduction on Duration of Therapy in Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
    Shadman, Mazyar
    Karve, Sudeep
    Patel, Sima
    Rava, Andrew
    Sun, Haiyan
    Howarth, Amanda
    Tomicki, Samantha
    Srivastava, Bhavini P.
    Stephens, Deborah M.
    [J]. BLOOD, 2023, 142
  • [10] Adverse drug events associated with ibrutinib for the treatment of elderly patients with chronic lymphocytic leukemia A systematic review and meta-analysis of randomized trials
    Zhou, Yanhua
    Lu, Hongtao
    Yang, Meifeng
    Xu, Chenhong
    [J]. MEDICINE, 2019, 98 (33)
12345